Parkman Healthcare Partners’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-305,353
| Closed | -$782K | – | 88 |
|
|
2022
Q3 | $782K | Sell |
305,353
-46,397
| -13% | -$119K | 0.22% | 78 |
|
|
2022
Q2 | $1.27M | Sell |
351,750
-282,076
| -45% | -$1.02M | 0.47% | 54 |
|
|
2022
Q1 | $3.94M | Buy |
633,826
+96,745
| +18% | +$601K | 1.15% | 33 |
|
|
2021
Q4 | $3.79M | Buy |
537,081
+61,714
| +13% | +$435K | 0.84% | 36 |
|
|
2021
Q3 | $3.32M | Buy |
475,367
+73,000
| +18% | +$510K | 0.84% | 35 |
|
|
2021
Q2 | $3.35M | Buy |
+402,367
| New | +$3.35M | 0.73% | 45 |
|